Literature DB >> 20393781

Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis.

M Vetter1, M Battegay, M Trendelenburg.   

Abstract

A 70 year-old female patient presented with fever, nausea and dyspnea. She had been receiving immunosuppressive therapy with methotrexate and prednisone for large-vessel vasculitis. The patient was shown to have coexistent Pneumocystis jiroveci pneumonia and primary cytomegalovirus (CMV) infection with presumed CMV pneumonitis and colitis. To our knowledge, this is the first case report on the occurrence of combined primary cytomegalovirus and Pneumocystis jiroveci infection in a patient with vasculitis. It illustrates the importance of being aware of the possibility of combined opportunistic infections in patients with rheumatologic diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393781     DOI: 10.1007/s15010-010-0024-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  18 in total

Review 1.  Immunosuppressive effects of beta-herpesviruses.

Authors:  Michael Boeckh; W Garrett Nichols
Journal:  Herpes       Date:  2003-05

2.  High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection.

Authors:  W Garrett Nichols; Lawrence Corey; Ted Gooley; Chris Davis; Michael Boeckh
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

3.  Opportunistic infections in patients with temporal arteritis treated with corticosteroids.

Authors:  S A Hedderwick; H F Bonilla; S F Bradley; C A Kauffman
Journal:  J Am Geriatr Soc       Date:  1997-03       Impact factor: 5.562

4.  Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.

Authors:  Stephanie A S Staras; Sheila C Dollard; Kay W Radford; W Dana Flanders; Robert F Pass; Michael J Cannon
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

5.  Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog.

Authors:  Parham Sendi; Angela Wolf; Peter Graber; Werner Zimmerli
Journal:  Scand J Infect Dis       Date:  2006

Review 6.  AIDS related opportunistic infections, going but not gone.

Authors:  Rafik Samuel; Robert L Bettiker; Byungse Suh
Journal:  Arch Pharm Res       Date:  2002-06       Impact factor: 4.946

7.  Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.

Authors:  F P Ognibene; J H Shelhamer; G S Hoffman; G S Kerr; D Reda; A S Fauci; R Y Leavitt
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

Review 8.  Current management of cytomegalovirus disease.

Authors:  P D Griffiths
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

9.  Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution.

Authors:  A M Jensen; J D Lundgren; T Benfield; T L Nielsen; J Vestbo
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

Review 10.  HIV-related pulmonary disorders: practice issues.

Authors:  S M Graham
Journal:  Ann Trop Paediatr       Date:  2007-12
View more
  6 in total

1.  Fever of unknown origin (FUO) in an immunocompetent adult due to cytomegalovirus (CMV) with polyclonal gammopathy.

Authors:  B A Cunha; J E Hage; Y Nouri
Journal:  Infection       Date:  2011-09-15       Impact factor: 7.455

2.  Pneumocystis jiroveci pneumonia with cytomegalovirus infection diagnosed by metagenomic next-generation sequencing in a patient with nephrotic syndrome: A case report.

Authors:  Qian Yu; Xuchun Ding; Wen Wang; Yafang Lou
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

3.  Detection of Cytomegalovirus in Bronchoalveolar Lavage Fluid from HIV-Positive Individuals with Community Acquired Pneumonia.

Authors:  Arati Mane; Pankaj Gujar; Shraddha Gaikwad; Tilak Dhamgaye; Arun Risbud
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 4.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

5.  Respiratory Multiplex Polymerase Chain Reaction: An Important Diagnostic Tool in Immunocompromised Patients.

Authors:  Amarjeet Kaur; Navin Kumar; Sharmila Sengupta; Yatin Mehta
Journal:  Indian J Crit Care Med       Date:  2017-04

6.  A co-infection of varicella-zoster virus and Pneumocystis jirovecii in a non-HIV immunocompromised patient: a case report.

Authors:  Hirotada Muramatsu; Akira Kuriyama; Yoshiaki Anzai; Tetsunori Ikegami
Journal:  BMC Infect Dis       Date:  2019-12-30       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.